# Cerberus Therapeutics, Inc. — Form D

Cerberus Therapeutics, Inc. of BOSTON, MA, a company, filed a Form D exempt-offering notice with the SEC on 2022-01-05. The offering totals $5.0M, of which $4.0M was reported sold. Industry: Biotechnology.

## Offering

- Filed: 2022-01-05
- Form: D
- Accession: 0001901829-22-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $5.0M
- Amount sold: $4.0M
- Remaining: $1.0M
- Investors: 1
- Date of first sale: 2021-12-22
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-427909

## Issuer

- Name: Cerberus Therapeutics, Inc.
- CIK: 0001901829
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2020
- Address: 6 W. HILL PL., BOSTON, MA, 02114
- Phone: 617-416-6228

## Officers, directors & promoters (5)

| Name | Role | Location |
| --- | --- | --- |
| Xiaowei Jin | Director | Cambridge, MA |
| Harvey Lodish | Director | Cambridge, MA |
| Novalia Pishesha | Director | Boston, MA |
| Novalia Pishesha | Executive Officer | Boston, MA |
| Xiaohong Sang | Executive Officer | Boston, MA |

## More

- [CIK 1901829 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1901829&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001901829-22-000001.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.